Physician profile
Benjamin W Cilento
NPI 1376525527
$16,565.79
in general payments reported to CMS, 2019-2025
30 companies · $5,613 in 2025
The $5,613 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $1,608 · 2021: $2,024 · 2022: $1,071 · 2023: $1,939 · 2024: $2,814 · 2025: $5,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,038 · Travel and Lodging: $1,272 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,038.18 |
| Travel and Lodging | $1,271.98 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $9,809.56 | 2019-2025 | Inspire |
| Stryker Corporation | $2,390.85 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System, Audion Et Dilation System |
| Intersect Ent, INC. | $1,141.42 | 2019-2022 | |
| Genzyme Corporation | $718.87 | 2022-2025 | |
| Medtronic, INC. | $459.33 | 2024-2025 | Propel, V-Loc 180, Sinuva |
| Regeneron Healthcare Solutions, INC. | $455.40 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $328.49 | 2022-2025 | Nucala |
| Abbvie INC. | $169.30 | 2023-2025 | Botox |
| Aerin Medical INC. | $168.97 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $137.50 | 2024 | Voquezna |
| Optinose US, INC. | $98.24 | 2023-2025 | |
| Merz North America, INC. | $94.79 | 2019 | |
| Acclarent, INC | $84.93 | 2019-2022 | |
| Hologic Sales and Service, LLC | $64.79 | 2025 | Coolseal Generator |
| Medinc of Texas | $52.73 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $41.83 | 2020-2022 | |
| Sanofi US Services INC. | $38.47 | 2025 | |
| Merck Sharp & Dohme LLC | $36.68 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $34.31 | 2023 | Seglentis |
| Medtronic USA, INC. | $34.15 | 2020 | |
| Neurent Medical Limited | $28.40 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Checkpoint Surgical, INC | $27.12 | 2024 | Checkpoint Stimulators |
| Integra Lifesciences Corporation | $26.12 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Zoll Respicardia, INC. | $25.88 | 2024 | Remede System |
| Phadia US INC. | $24.99 | 2024 | Immunocap |
| Kaleo, INC. | $22.47 | 2022 | |
| Ambu INC. | $22.25 | 2025 | |
| Community Blood Center | $14.43 | 2021 | |
| Lilly USA, LLC | $13.52 | 2025 | Zepbound |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cilento listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.